Search results for: 'know'

11 Mar 2020  |  North America  |  Market Outlook

Global Homes and Buildings (H&B) Industry Outlook, 2020

Artificial Intelligence (AI)-driven Solutions, Energy Efficiency Directives, Sustainability Targets, Construction Activities, and Stringent Building Safety Codes Drive Overall Industry Growth

Infographics

×

Key Issues Addressed

The homes and buildings (H&B) industry is driven by the penetration of IoT at the field level of buildings, by the emerging adoption of artificial intelligence (AI)-driven solutions at the management level, and by cloud-based data analytics. These technologies are significantly impacting the smart homes, LED lighting, building automation, and build...

19 Apr 2021  |  North America  |  Market Outlook

Digital and Outcome-linked Service Innovations to Power the Global Homes and Buildings Industry, Outlook 2021

Future Growth Potential Driven by Resilient and Sustainable Business Models

Infographics

×

Key Issues Addressed

The COVID-19 pandemic has impacted nearly every sector and has forced various industries to undergo business transformation initiatives to adapt to the new normal environment. The Homes and Buildings (H&B) industry is no exception and is expected to face an acute recovery challenge both from the supply and demand side of the industry in 2021. As ho...

28 Aug 2019  |  Global  |  Market Research

Global Home Energy Management Systems (HEMS) and Building Energy Management Systems (BEMS) Market, Forecast to 2025

Energy Efficiency Legislation, Customer Awareness, and Commitment to Sustainability are Crucial for Accelerated Market Growth

Infographics

×

Key Issues Addressed

The Home Energy Management Systems (HEMS) and Building Energy Management Systems (BEMS) market is dynamic and poised for accelerated growth for the next 7 years. BEMS is primarily driven by the trend of high peak demand charges, customers’ commitment towards sustainability, energy efficiency legislation, state incentives for buildings to install en...

Pharmaceutical drug discovery and development processes suffer from declining success rates and a stagnant pipeline. Artificial Intelligence (AI) supported by Big Data could be a key element that can provide an effectual solution. There has been a rapid growth in the data generated within the life sciences and pharmaceutical industries. This stems ...